About Polaris
Polaris is a company based in Pleuven (France) founded in 1994. It operates as a B2B2C and HealthTech. Polaris has raised $13.9 million across 2 funding rounds from investors including Seventure Partners. Polaris offers products and services including Omega-3 Oils (Microalgae) and Omega-3 Oils (Marine). Polaris operates in a competitive market with competitors including Solutex, AlgaeCytes, Oceans Omega, Algisys and Zinzino, among others.
- Headquarter Pleuven, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.9 M (USD)
in 2 rounds
-
Latest Funding Round
$5.52 M (USD), Series A
Mar 30, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polaris
Polaris offers a comprehensive portfolio of products and services, including Omega-3 Oils (Microalgae) and Omega-3 Oils (Marine).
High-concentration DHA and EPA oils are produced sustainably.
Marine-derived oils with exceptional stability are offered widely.
People of Polaris
Unlock access to complete
Unlock access to complete
Funding Insights of Polaris
Polaris has successfully raised a total of $13.9M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.52 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Polaris
Polaris has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Seventure Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked |
Investor details for Polaris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polaris
Investment portfolio details for Polaris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polaris
Detailed financials for Polaris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polaris Comparisons
Peer comparison for Polaris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polaris
Polaris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Solutex, AlgaeCytes, Oceans Omega, Algisys and Zinzino, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutex is recognized as a leading manufacturer of omega-3 ingredients.
|
|
| Locked | Locked | Locked |
Omega 3 oils and bio-actives are manufactured from freshwater algae.
|
|
| Locked | Locked | Locked |
Omega-3 concentrates are developed and marketed for functional foods.
|
|
| Locked | Locked | Locked |
Algal-based EPA omega-3 oils and vegan protein are produced.
|
|
| Locked | Locked | Locked |
Personalized supplements are manufactured based on omega-6/omega-3 ratio tests.
|
Detailed competitors of Polaris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polaris
Complete news archive for Polaris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polaris
Polaris was founded in 1994 and raised its 1st funding round 15 years after it was founded.
Polaris is headquartered in Pleuven, France. It is registered at Pleuven, Finistere, France.
Polaris is a funded company, having raised a total of $13.9M across 2 funding rounds to date.
Polaris is established as a key player in the production of concentrated EPADHA Omega-3 fatty acids and a significant contributor to GreenTech in France. The company is specialized in lipochemistry, focusing on the synthesis and transformation of polyunsaturated fatty acids through environmentally friendly processes. Solutions are provided for health benefits in areas such as sleep, stress, vitality, immunity, cardiovascular health, and brain function. Products are developed from sustainable marine sources and renewable microalgae oils, targeting sectors like specialized nutrition, infant nutrition, functional foods, and nutraceuticals. Innovations including Qualitysilver for oil stability and Sensory for organoleptic performance are integrated into their offerings.
Polaris's top competitors include Zinzino, AlgaeCytes and Algisys.
Polaris offers Omega-3 Oils (Microalgae) and Omega-3 Oils (Marine).
Polaris has 1 investor. Key investors include Seventure Partners.